May 13 (Reuters)-
Medrx.Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2022 Mar 31, 2021 Dec 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 1 mln 7 mln 289 mln
(-73.7 pct)
Operating loss 189 mln loss 262 mln loss 1.00
Recurring loss 198 mln loss 261 mln loss 1.00
Net loss 196 mln loss 262 mln loss 1.01
EPS loss 8.01 yen loss 13.37 yen loss 40.91 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Medrx.Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T